Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...